NextGen Biomed 2025, London, UK, March 12-14, 2025

‍

genOway's presentation on Thursday, March 13, 2025 | 4.30 p.m. GMT:

‍

How to enhance translatability of immunotherapies in preclinical models

‍

• Outlining genO-BRGSF-HIS mice: a CD34⁺-reconstituted model with functional human lymphoid and myeloid compartments without side effects
• Demonstrating the recruitment of human immune cells to the affected area, as well as their activation status
• Highlighting the key role of myeloid compartment in the translatable assessment of biologic's safety in humanized models

‍

Come visit us at Booth #22!

If you'd like to get in touch, fill out the contact form below